Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine applies a thermodynamic, computational discovery platform - ProMIS and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product portfolio includes PMN310 / Amyloid-beta, PMN267 / TDP-43, and PMN442 / Alpha-synuclein. The Company plans to investigate additional synucleinopathies, including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Its wholly owned subsidiary is ProMIS Neurosciences (US) Inc.


NDAQ:PMN - Post by User

Comment by FarmerBetsyon Jan 04, 2024 5:46pm
198 Views
Post# 35811432

RE:RE:RE:RE:Good Riddance

RE:RE:RE:RE:Good Riddance

Yes, that 14million trading day on July 17/23 is not defendable by any means. From the beginning of Jan /2023 to that day they had a total of  402,455 Nasdaq shares traded. Based on past and current trades, they would need years of trading to add up to 14 million shares. Obviously rigged they screwed up!! If this company ever makes it out to the PUBLIC that might be one of the reasons Gail is gone, it just looks to crooked, the stock falling from $6 to $2 in a few weeks then doubling the amount of common stock in August to BOD's , Mpt, and Boston group. 

Gail was well looked after , the company had 3 easy objectives last year and they couldn't even  get them done. Gail a $500k severance what a treat, obviously the real company goals were achieved. Maybe she is going to work for Jeremy Sclar or Michael Gordon?, they both reported SEC events on Christmas abd Boxing day.

<< Previous
Bullboard Posts
Next >>